COVID-19 Vaccination Strategy in Germany

Abstract

Vaccines are needed to reduce the mortality and economic damage caused by COVID-19. To date there are three approved vaccines in the European Union created by BioNTech/Pfizer, Moderna and AstraZeneca, but due to the high demand globally there are still shortages, forcing governments to create strategies to immunize their population prioritizing their citizens according to their risk evaluation and their systemic relevance. This review specifies on the German vaccination strategy.